IRONWOOD PHARMACEUTICALS INC shareholders Q2 2023

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

IRONWOOD PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 18,417,000$18,473,5401.50%
III Capital Management 23,900,000$23,990,1981.43%
SHENKMAN CAPITAL MANAGEMENT INC 15,432,000$15,550,0401.21%
ABSOLUTE INVESTMENT ADVISERS, LLC 7,571,000$7,587,8961.07%
TENOR CAPITAL MANAGEMENT Co., L.P. 37,010,000$37,148,6080.78%
DLD Asset Management, LP 5,000,000$5,050,0000.55%
Boussard & Gavaudan Investment Management LLP 4,698$4,731,8020.45%
Worth Venture Partners, LLC 680,000$684,7440.37%
CAPSTONE INVESTMENT ADVISORS, LLC 40,200,000$40,617,1200.20%
WOLVERINE ASSET MANAGEMENT LLC 9,891,000$9,931,3680.12%
Calamos Advisors LLC 12,500,000$12,538,3750.06%
BOOTHBAY FUND MANAGEMENT, LLC 2,208,000$2,233,5850.05%
Leucadia National 1,293,000$1,298,1630.01%
Citadel Advisors 19,017,000$19,092,3180.00%
LAKE STREET ADVISORS GROUP, LLC 47,000$470.00%
BANK OF MONTREAL /CAN/ 4,800,000$4,815,9360.00%
JANE STREET GROUP, LLC 3,000,000$3,012,5100.00%
D.A. DAVIDSON & CO. 135,000$135,0810.00%
Cetera Advisor Networks LLC 17,000$17,0060.00%
Cetera Advisors LLC 21,000$21,0080.00%

This page lists IRONWOOD PHARMACEUTICALS INC's shareholders in Q2 2023. To view IRONWOOD PHARMACEUTICALS INC's shareholder history, click here.